MedDataX Logo

Outcome of Patients Treated With ECLS

NCT ID: NCT04405817

Last Updated: 2020-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-01

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Extracorporeal life support (ECLS), also called extracorporeal membrane oxygenation (ECMO), is an extracorporeal technique of providing effective circulatory and (or) respiratory failure, with a growing number of critically ill patients benefit from it. The aim of this study is to investigate the outcome of patients treated With ECMO, and to evaluate the short-term and long-term outcomes of patients with ECLS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pre-hospital ECMO or Conventional Resuscitation for Refractory Cardiac Arrest

NCT06177730

Out of Hospital Cardiac Arrest
NOT_YET_RECRUITING NA

Refractory IHCA and OHCA Treated With ECMO

NCT01298050

Cardiac Arrest
UNKNOWN

ECMO LEft Ventricle UNloading Strategy

NCT06766006

Shock, Cardiogenic Cardiac Arrest Extracorporeal Membrane Oxygenation Complication
RECRUITING

Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - "HemodynamECMOnitoring-VV Study"

NCT06593717

ECMO Treatment ARDS Pneumonia +3 more
RECRUITING NA

The Effect of Simultaneous Renal Replacement Therapy on Extracorporeal Membrane Oxygenation Support for Cardiogenic Shock Patients

NCT02870946

Cardiogenic Shock
UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiogenic Shock Cardiac Arrest Heart Failure Acute Respiratory Failure Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ECMO

ECMO for circulatory and/or respiratory support

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients receiving ECMO for circulatory and/or respiratory support

Exclusion Criteria

* Refusal of consent
Minimum Eligible Age

1 Year

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nanjing Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hong Liu

Investigator of Department of Cardiac Surgery

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yong-feng Shao

Role: STUDY_DIRECTOR

The First Affiliated Hospital with Nanjing Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The first affiliated hospital of nanjing medical university

Nanjing, Jiangsu, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hong Liu, MD

Role: CONTACT

[email protected]
18801281613

Yong-feng Shao, MD

Role: CONTACT

[email protected]
02568303100

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hong Liu, MD

Role: primary

[email protected]
188012181613

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECLS-Jsph

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Resuscitation Fluid Choice and Clinical Outcomes
NCT02641119 COMPLETED
Timing and Dose of Fluid Deresuscitation in Critically Ill Patients
NCT07275658 RECRUITING
Fluid Balance Neutralization During CRRT (Continuous Renal Replacement Therapy)
NCT04801784 COMPLETED NA
Hemodynamic Optimization By Non-Invasive Determination Of Cardiac Output In Critically Ill Patients
NCT01309724 COMPLETED NA
Intrarenal Venous Flow Change During Fluid Removal in Critically Ill Patients: A Prospective Exploratory Study
NCT06216119 COMPLETED
Volume Resuscitation in Cirrhosis With Sepsis Induced Hypotension
NCT05059795 COMPLETED
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
NCT05306392 UNKNOWN NA
Non-invasive Fluid Management
NCT02892799 UNKNOWN NA
Non-invasive Goal-directed thErapy oN cIrcUlatory Shock
NCT05336357 RECRUITING NA
The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality
NCT04508296 COMPLETED NA
Transcutaneous pO2, Transcutaneous pCO2 and Central Venous SO2 Variations to Define Fluid Responsiveness
NCT01941472 COMPLETED NA
Effect of Oral Water on the Quality of Volume Expansion in Resuscitation Patients
NCT03951519 COMPLETED NA
Lactate Clearance Goal-directed Therapy in Sepsis
NCT03256461 UNKNOWN NA
"Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS"
NCT04996394 COMPLETED
A Prospective Observational Study of the Expectations and Physiological Effects of Fluid Bolus Therapy
NCT03178578 UNKNOWN
Serum Electrolyte Abnormalities as Prognostic Factor for Outcome in Critically Ill Children
NCT07205562 NOT_YET_RECRUITING
Study of End Tidal Carbon Dioxide (EtCO2) Variation After an End- Expiratory Occlusion Test as a Predictive Criteria of Fluid Responsiveness in Mechanically Ventilated Patients
NCT04889807 COMPLETED
Time Course Evolution of Cardiac Output
NCT03694717 COMPLETED
When Heparin Stopped for Anticoagulation During ECMO Decannulation
NCT05239637 UNKNOWN NA
Feasibility and Safety of Delivering a Ketone Drink to Comatose Survivors of Out-of-hospital Cardiac Arrest
NCT03226197 COMPLETED NA
Safety Study of Inhaled Saline in Acute Lung Injury
NCT01713595 WITHDRAWN PHASE1
VExUS-guided Fluid Management in the ICU
NCT07291778 NOT_YET_RECRUITING NA
Intraosseous Versus Intravenous Vascular Access During Resuscitation Following Out-of-Hospital Cardiac Arrest
NCT04130984 UNKNOWN NA
The Enteral Resuscitation In Intensive Care Pilot- Study
NCT05595395 UNKNOWN NA
Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS
NCT04493242 COMPLETED PHASE2